Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.7150 (0.59%) ($67.7150 - $67.7150) on Wed. Jul. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 31 | Latest Price | $67.7150(0.59%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(48%) IBB(45%) XHB(41%) UNG(37%) VFMO(35%) | Factors Impacting LGND price | LGND will decline at least -1.06% in a week (0% probabilities). UUP(-28%) TBT(-23%) VXX(-20%) XLU(-10%) VIXM(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $63.14(-6.76%) | Resistance Level | $69.16 | 5 Day Moving Average | $67.36(0.53%) | 10 Day Moving Average | $67.72(-0.01%) | 20 Day Moving Average | $69.16(-2.09%) | To recent high | -15% | To recent low | 1.7% | Market Cap | $1.088b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |